Range Low Price High Price Comment
30 days $2.36 $7.67 Tuesday, 30th Apr 2024 BPTH stock ended at $2.83. This is 0.702% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 5.09% from a day low at $2.71 to a day high of $2.85.
90 days $0.352 $7.67
52 weeks $0.320 $7.67

Historical Bio-Path Holdings prices

Date Open High Low Close Volume
Mar 09, 2016 $17.60 $18.50 $17.20 $18.50 5 180
Mar 08, 2016 $17.30 $19.30 $17.00 $17.20 29 620
Mar 07, 2016 $16.60 $17.30 $15.90 $17.00 3 650
Mar 04, 2016 $19.00 $19.00 $15.90 $15.90 26 390
Mar 03, 2016 $19.10 $19.30 $18.50 $18.50 8 660
Mar 02, 2016 $18.50 $19.10 $18.10 $19.10 15 110
Mar 01, 2016 $19.00 $19.00 $16.80 $18.50 11 950
Feb 29, 2016 $17.50 $19.70 $16.00 $17.80 9 140
Feb 26, 2016 $17.80 $19.00 $17.70 $17.70 6 610
Feb 25, 2016 $16.00 $17.80 $16.00 $17.50 11 740
Feb 24, 2016 $15.60 $17.20 $15.30 $17.20 11 720
Feb 23, 2016 $15.40 $15.60 $14.80 $15.40 1 920
Feb 22, 2016 $15.30 $15.60 $15.00 $15.50 4 430
Feb 19, 2016 $14.80 $15.70 $14.80 $15.00 6 480
Feb 18, 2016 $14.70 $15.20 $14.50 $15.00 5 790
Feb 17, 2016 $14.20 $14.70 $13.70 $14.70 8 790
Feb 16, 2016 $13.80 $14.10 $13.70 $14.00 3 870
Feb 12, 2016 $13.70 $13.80 $13.50 $13.70 1 280
Feb 11, 2016 $13.60 $13.70 $13.40 $13.50 3 570
Feb 10, 2016 $13.80 $13.90 $13.40 $13.50 670
Feb 09, 2016 $13.70 $13.70 $13.40 $13.40 1 700
Feb 08, 2016 $14.00 $14.00 $13.60 $13.70 2 220
Feb 05, 2016 $13.80 $14.10 $13.10 $13.50 4 280
Feb 04, 2016 $13.70 $14.30 $13.70 $14.10 4 560
Feb 03, 2016 $13.90 $13.90 $13.40 $13.70 1 940
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT